Tacrolimus Ring-opening Impurity
|
|
Tacrolimus Ring-opening Impurity 속성
- 끓는 점
- 873.1±75.0 °C(Predicted)
- 밀도
- 1.17±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 13.76±0.70(Predicted)
안전
Tacrolimus Ring-opening Impurity C화학적 특성, 용도, 생산
Tacrolimus Ring-opening Impurity 준비 용품 및 원자재
원자재
준비 용품
Tacrolimus Ring-opening Impurity 공급 업체
글로벌( 34)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Guangzhou Tosun Pharmaceutical Limited | +8618922120635 |
sales@toref-standards.com | China | 1000 | 58 |
Wuxi Minglu Medicine technology Co.,Ltd. | 0510-88726693 |
3204601684@qq.com | China | 2215 | 58 |
Guangzhou Alice Biotechnology Co., Ltd. | 0898-31318057 13265151549 |
3080931802@qq.com | China | 161 | 58 |
BOC Sciences | 1-631-485-4226; 16314854226 |
info@bocsci.com | United States | 14059 | 65 |
ChemStrong Scientific Co.,Ltd | 0755-0755-66853366 13670046396 |
sales@chem-strong.com | China | 18021 | 56 |
Shanghai Kewel Chemical Co., Ltd. | 021-64609169 18901607656 |
greensnown@163.com | China | 9911 | 50 |
TOSUN PHARM | 020-61855200 13326451905 |
260366801@qq.com | China | 7725 | 58 |
Guangzhou Dreampharm Biotechnology Co., Ltd. | 020-36607679 17825480238 |
3008233717@qq.com | China | 9919 | 12 |
Guangzhou Jiuzhi Pharmaceutical Technology Co., Ltd. | 020-89854820 |
sales@jzpharma.cn | China | 1081 | 58 |
Jinan blalong chemical co. LTD | 2710913286@.com |
1513643261@qq.com | China | 14253 | 58 |
Tacrolimus Ring-opening Impurity 관련 검색:
TacroliMus Methyl Acryl Aldehyde
Iso-FK-506 (iso-TacroliMus)
Ascomycin
Δ23-FK-506
Tacrolimus Hydroxy Acid Impurity
8-EpitacroliMus
Dabigatran etexilate Impurity R
Dabigatran iMpurity J
Dabigatran Etexilate iMpurity I
Dabigatran Impurity p
Dabigatran Etexilate iMpurity H
Dabigatran iMpurity L
Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity)
N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide
Dabigatran Impurity 9
Dabigatran Etexilate iMpurity G
(E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity
15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,3-[(1E)-2-[(1R,3R,4R)-3,4-dihydroxycyclohexyl]-1-methylethenyl]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-,(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-